Skip to main content

Want a detailed portfolio tracker?

LAVA Therapeutics (LVTX) P/E (2024 - 2025)

LAVA Therapeutics (LVTX) P/E from Apr 1, 2024 to Dec 5, 2025. The TTM LAVA Therapeutics (LVTX) P/E is -1.97. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of LAVA Therapeutics (LVTX)

YearP/EChange
2025-1.97+94.88%
2024-1.01N/A

Comparison LAVA Therapeutics (LVTX) P/E with competitors

LAVA Therapeutics (LVTX) P/E is -1.97.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.22%
ENLVEnlivex Ltd0.07-103.79%
FGENFibroGen Inc0.24-112.16%
CHRSCoherus Biosciences Inc0.85-142.99%
FBIOFortress Biotech Inc0.95-148.08%
ORMPOramed Pharmaceuticals Inc1.50-176.15%
AGENAgenus Inc3.01-252.48%
INVAInnoviva Inc3.15-259.79%
VXRTVaxart Inc3.55-279.84%
CRMDCorMedix Inc3.63-283.83%
CVACCureVac N.V.4.45-325.23%
GLPGGalapagos NV4.86-346.17%
SRPTSarepta Therapeutics Inc4.88-347.34%
ABEOAbeona Therapeutics Inc5.39-372.95%
ABUSArbutus Biopharma Corp5.60-383.49%
ZVRAZevra Therapeutics Inc5.89-398.27%
SPROSpero Therapeutics Inc6.23-415.55%
CGENCompugen Ltd6.31-419.88%
RIGLRigel Pharmaceuticals6.87-448.16%
SLXNSilexion Therapeutics Corp7.30-469.64%
OMEROmeros Corporation9.26-569.08%
AUPHAurinia Pharmaceuticals Inc9.58-585.60%
PLXProtalix BioTherapeutics Inc10.89-651.77%
ACADAcadia Pharmaceuticals Inc11.73-694.20%
TBPHTheravance Biopharma Inc12.26-721.24%
ADMAAdma Biologics Inc12.42-729.14%
HRMYHarmony Biosciences Holdings Inc13.82-800.18%
SABSSAB Biotherapeutics Inc14.14-816.19%
NAGENiagen Bioscience Inc14.82-850.73%
INCYIncyte Corp15.82-901.62%
REGNRegeneron Pharmaceuticals Inc15.86-903.35%
PBYIPuma Biotechnology Inc17.32-977.27%
CPRXCatalyst Pharmaceuticals Inc17.44-983.53%
EXELExelixis Inc17.54-988.53%
TGTXTG Therapeutics Inc18.97-1060.88%
MDXGMimedx Group Inc20.55-1141.26%
XOMAXOMA Royalty Corp22.87-1258.94%
ARGXArgen X SE24.30-1331.05%
CTMXCytomX Therapeutics Inc24.82-1357.55%
XOMAOXOMA Royalty Corp25.34-1384.08%
HALOHalozyme Therapeutics Inc25.62-1398.22%
XOMAPXOMA Royalty Corp25.67-1400.57%
VRTXVertex Pharmaceuticals Inc27.99-1518.34%
RPRXRoyalty Pharma plc - Class A28.69-1553.44%
SLNOSoleno Therapeutics Inc29.02-1570.05%
ASNDAscendis Pharma A/S30.09-1624.27%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2020.80%
APLSApellis Pharmaceuticals Inc39.02-2077.00%
BMRNBiomarin Pharmaceutical Inc42.21-2238.65%
KRYSKrystal Biotech Inc45.34-2397.31%
ONCBeiGene Ltd69.54-3623.24%
PHARPharming Group N.V.75.03-3901.14%
TECHBio-Techne Corp101.96-5265.69%
VCELVericel Corp109.92-5669.13%
ALNYAlnylam Pharmaceuticals Inc117.96-6076.66%
GMABGenmab140.29-7207.78%
TLXTelix Pharmaceuticals Ltd162.15-8315.42%
CORTCorcept Therapeutics Inc212.86-10884.35%